Risk factors and populations at risk: Selection of patients for screening for Barrett's oesophagus

Best Practice and Research: Clinical Gastroenterology

Volumn 29, Issue 1, 2015, Pages 41-50

  Rubenstein, Joel H ^a,b   Thrift, Aaron P ^c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Barrett's oesophagus; Mass screening; Oesophageal neoplasms; Risk assessment

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ABDOMINAL OBESITY; AGE DISTRIBUTION; ANXIETY; AUSTRALIA; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CLINICAL DECISION MAKING; COLORECTAL CANCER; COUGHING; DATA BASE; DEPRESSION; DYSPHAGIA; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HIGH RISK POPULATION; HOARSENESS; HUMAN; IRRITABLE COLON; MENTAL STRESS; MODEL; PATIENT SELECTION; PRACTICE GUIDELINE; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SOMATIZATION; THORAX PAIN; TOBACCO USE; UNITED STATES; WEIGHT REDUCTION; ADENOCARCINOMA; COMPLICATION; EARLY CANCER DIAGNOSIS; ESOPHAGEAL NEOPLASMS; PRECANCEROUS CONDITIONS; PROCEDURES; RISK FACTOR;

ADENOCARCINOMA; BARRETT ESOPHAGUS; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; PATIENT SELECTION; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 84925146660     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2014.11.009     Document Type: Review

References (52)

1. H. Pohl, and H.G. Welch The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 2 2005 Jan 19 142 146 PubMed PMID: 15657344
2. G.S. Cooper, T.D. Kou, and A. Chak Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends Am J Gastroenterol 104 6 2009 1356
3. G.S. Cooper, Z. Yuan, A. Chak, and A.A. Rimm Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the oesophagus and gastric cardia Cancer 95 1 2002 Jul 1 32 38 PubMed PMID: 12115314
4. D.A. Corley, T.R. Levin, L.A. Habel, N.S. Weiss, and P.A. Buffler Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 3 2002 633 640
5. J.H. Rubenstein, A. Sonnenberg, J. Davis, L. McMahon, and J.M. Inadomi Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans Gastrointest Endosc 68 5 2008 849 855 PubMed PMID: PMID: 18547567
6. D.A. Corley, K. Mehtani, C. Quesenberry, W. Zhao, J. de Boer, and N.S. Weiss Impact of endoscopic surveillance on mortality from Barrett's oesophagus-associated esophageal adenocarcinomas Gastroenterology 145 2 2013 Aug 312-319 e1. PubMed PMID: 23673354. Pubmed Central PMCID: PMC3767470. Epub 2013/05/16. eng
7. S.J. Spechler, P. Sharma, R.F. Souza, J.M. Inadomi, and N.J. Shaheen American Gastroenterological Association medical position statement on the management of Barrett's oesophagus Gastroenterology 140 3 2011 Mar 1084 1091 PubMed PMID: 21376940. English
8. K.K. Wang, R.E. Sampliner Practice Parameters Committee of the American College of G Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's oesophagus Am J Gastroenterol 103 3 2008 Mar 788 797 PubMed PMID: 18341497
9. W. Hirota, M. Zuckerman, D. Adler, R. Davila, J. Egan, and J. Leighton ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract Gastrointest Endosc 63 4 2006 570 580
10. H.B. El-Serag Time trends of gastroesophageal reflux disease: a systematic review Clin Gastroenterol Hepatol 5 1 2007 Jan 17 26 PubMed PMID: 17142109
11. J.R. Kramer, M.H. Shakhatreh, A.D. Naik, Z. Duan, and H.B. El-Serag Use and yield of endoscopy in patients with uncomplicated gastroesophageal reflux disorder JAMA Intern Med 174 3 2014 462 465
12. H. El-Serag, M. Hinojosa-Lindsey, Z. Duan, J. Hou, A.D. Naik, and R.L. Street Timing and diagnostic yield of endoscopy among patients with GERD (abstract) Digestive diseases week 2012 Mo1029
13. E.S. Dellon, C.F. Carroll, J.K. Allen, S. Cook, A.F. Peery, and N.J. Shaheen A decade of increased gastrointestinal endoscopy utilization and costs in the United States, 2000-2009 (Abstract) Digestive diseases week 2012 ASGE 67
14. A. Sonnenberg, S.L. Amorosi, M.J. Lacey, and D.A. Lieberman Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database Gastrointest Endosc 67 3 2008 Mar 489 496 PubMed PMID: 18179793. English
15. L.C. Seeff, T.B. Richards, J.A. Shapiro, M.R. Nadel, D.L. Manninen, and L.S. Given How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity Gastroenterology 127 6 2004 Dec 1670 1677 PubMed PMID: 15578503. English
16. G.S. Dulai, S. Guha, K.L. Kahn, J. Gornbein, and W.M. Weinstein Preoperative prevalence of Barrett's oesophagus in esophageal adenocarcinoma: a systematic review Gastroenterology 122 1 2002 Jan 26 33 PubMed PMID: 11781277. English
17. R.E. Sampliner Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's oesophagus. The Practice Parameters Committee of the American College of Gastroenterology Am J Gastroenterol 93 7 1998 Jul 1028 1032 PubMed PMID: 9672324
18. R.E. Sampliner Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's oesophagus Am J Gastroenterol 97 8 2002 1888 1895
19. K.K. Wang, M. Wongkeesong, and N.S. Buttar American Gastroenterological Association medical position statement: role of the gastroenterologist in the management of esophageal carcinoma Gastroenterology 128 5 2005 May 1468 1470 PubMed PMID: 15887128
20. J.H. Rubenstein, and J.B. Taylor Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux Aliment Pharmacol Ther 32 10 2010 Nov 1222 1227 PubMed PMID: 20955441. English
21. J.H. Rubenstein Risk factors for Barrett's oesophagus Curr Opin Gastroenterol 30 4 2014 Jul 408 414 PubMed PMID: 24859804. Epub 2014/05/27. eng
22. L.B. Gerson, R. Edson, P.W. Lavori, and G. Triadafilopoulos Use of a simple symptom questionnaire to predict Barrett's oesophagus in patients with symptoms of gastroesophageal reflux Am J Gastroenterol 96 7 2001 Jul 2005 2012 PubMed PMID: 11467625
23. G.R. Locke, A.R. Zinsmeister, and N.J. Talley Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc 58 5 2003 Nov 661 670 PubMed PMID: 14595298
24. M.A. Eloubeidi, and D. Provenzale Clinical and demographic predictors of Barrett's oesophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans J Clin Gastroenterol 33 4 2001 306 309
25. K.S. Nason, P.P. Wichienkuer, O. Awais, M.J. Schuchert, J.D. Luketich, and R.W. O'Rourke Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis Arch Surg 146 7 2011 Jul 851 858 PubMed PMID: 21768433. English
26. Q.K. Lippmann, S.D. Crockett, E.S. Dellon, and N.J. Shaheen Quality of life in GERD and Barrett's oesophagus is related to gender and manifestation of disease Am J Gastroenterol 104 11 2009 Nov 2695 2703 PubMed PMID: 19755967. Pubmed Central PMCID: Source: NLM. NIHMS280265. Source: NLM. PMC3073722. English
27. P.J. Kahrilas, N.J. Shaheen, M.F. Vaezi, S.W. Hiltz, E. Black, and I.M. Modlin American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease Gastroenterology 135 4 2008 Oct 1383 1391 PubMed PMID: 18789939. English
28. P.J. Kahrilas, C.W. Howden, and N. Hughes Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease Am J Gastroenterol 106 8 2011 Aug 1419 1425 quiz 26. PubMed PMID: 21537361. English
29. P.J. Kahrilas, N. Hughes, and C.W. Howden Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease Gut 60 11 2011 Nov 1473 1478 PubMed PMID: 21508423. English
30. R. Fass Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics J Clin Gastroenterol 41 2 2007 Feb 131 137 PubMed PMID: 17245209. English
31. I. Mainie, R. Tutuian, S. Shay, M. Vela, X. Zhang, and D. Sifrim Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring Gut 55 10 2006 Oct 1398 1402
32. N. Sharma, A. Agrawal, J. Freeman, M.F. Vela, and D. Castell An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring Clin Gastroenterol Hepatol 6 5 2008 May 521 524 PubMed PMID: 18356117
33. B. Nojkov, J.H. Rubenstein, S.A. Adlis, M.J. Shaw, R. Saad, and J. Rai The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease Aliment Pharmacol Ther 27 6 2008 Mar 15 473 482 PubMed PMID: 18194508
34. J.H. Rubenstein, B. Nojkov, S. Korsnes, S.A. Adlis, M.J. Shaw, and B. Weinman Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome Aliment Pharmacol Ther 26 3 2007 Aug 1 443 452 PubMed PMID: 17635379. English
35. M.B. Cook, C.P. Wild, and D. Forman A systematic review and meta-analysis of the sex ratio for Barrett's oesophagus, erosive reflux disease, and nonerosive reflux disease Am J Epidemiol 162 11 2005 Dec 1 1050 1061 PubMed PMID: 16221805. English
36. J.H. Rubenstein, N. Mattek, and G. Eisen Age- and sex-specific yield of Barrett's oesophagus by endoscopy indication Gastrointest Endosc 71 1 2010 Jan 21 27 PubMed PMID: 19748616. Epub online September 14, 2009 as DOI: 10.1016/j.gie.2009.06.035. English
37. J.B. Taylor, and J.H. Rubenstein Meta-analyses of the effect of symptoms of gastroesophageal reflux on risk of Barrett's oesophagus Am J Gastroenterol 105 8 2010 1730 1737 Pubmed Central PMCID: PMID: 20485283. NIHMS: 217992
38. M.B. Cook, F. Kamangar, D.C. Whiteman, N.D. Freedman, M.D. Gammon, and L. Bernstein Cigarette smoking and adenocarcinomas of the oesophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium J Natl Cancer Inst 102 17 2010 Sep 8 1344 1353 PubMed PMID: 20716718. Pubmed Central PMCID: Source: NLM. PMC2935475. English
39. D.A. Corley, A. Kubo, and W. Zhao Abdominal obesity and the risk of esophageal and gastric cardia carcinomas Cancer Epidemiol Biomarkers Prev 17 2 2008 Feb 352 358 PubMed PMID: 18268119. English
40. J.H. Rubenstein, H. Morgenstern, W.D. Chey, J. Murray, J. Scheiman, and P. Schoenfeld Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett's oesophagus Gut 63 2 2014 230 235
41. T.L. Vaughan, A.R. Kristal, P.L. Blount, D.S. Levine, P.C. Galipeau, and L.J. Prevo Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's oesophagus Cancer Epidemiol Biomarkers Prev 11 8 2002 Aug 745 752 PubMed PMID: 12163328
42. J.H. Rubenstein, J.M. Scheiman, S. Sadeghi, D. Whiteman, and J.M. Inadomi Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies Am J Gastroenterol 106 2 2011 Feb 254 260 PubMed PMID: 21139576. English
43. J.H. Rubenstein, H. Morgenstern, H. Appelman, J. Scheiman, P. Schoenfeld, and L.F. McMahon Jr. Prediction of Barrett's oesophagus among men Am J Gastroenterol 108 3 2013 Mar 353 362 PubMed PMID: 23318485. English
44. A.P. Thrift, B.J. Kendall, N. Pandeya, T.L. Vaughan, D.C. Whiteman Study of Digestive H A clinical risk prediction model for Barrett oesophagus Cancer Prev Res Phila Pa 5 9 2012 Sep 1115 1123 PubMed PMID: 22787114. English
45. A.P. Thrift, J.M. Garcia, and H.B. El-Serag A multibiomarker risk score helps predict risk for Barrett's oesophagus Clin Gastroenterology Hepatology 2013 Published online December 19, 2013 at http://dx.doi.org/10.1016/j.cgh.2013.12.014
46. A.P. Thrift, B.J. Kendall, N. Pandeya, and D.C. Whiteman A model to determine absolute risk for esophageal adenocarcinoma Clin Gastroenterol Hepatol 11 2 2013 Feb 138-144.e2. PubMed PMID: 23103823. English
47. S.R. Kadri, P. Lao-Sirieix, M. O'Donovan, I. Debiram, M. Das, and J.M. Blazeby Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study Bmj 341 2010 2010-09-10 00:00:00
48. N.J. Shaheen, D.S. Weinberg, T.D. Denberg, R. Chou, A. Qaseem, and P. Shekelle Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines Committee of the American College of Physicians Ann Intern Med 157 11 2012 808 816
49. J.A. Evans, D.S. Early, N. Fukami, T. Ben-Menachem, V. Chandrasekhara, and K.V. Chathadi The role of endoscopy in Barrett's oesophagus and other premalignant conditions of the oesophagus Gastrointest Endosc 76 6 2012 Dec 1087 1094 PubMed PMID: 23164510. English
50. R.C. Fitzgerald, M. di Pietro, K. Ragunath, Y. Ang, J.-Y. Kang, and P. Watson British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus Gut 63 1 2014 7 42 October 28, 2013
51. B. Rockhill, D. Spiegelman, C. Byrne, D.J. Hunter, and G.A. Colditz Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention J Natl Cancer Inst 93 5 2001 Mar 7 358 366 PubMed PMID: 11238697. English
52. J.A. Tice, S.R. Cummings, R. Smith-Bindman, L. Ichikawa, W.E. Barlow, and K. Kerlikowske Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model Ann Intern Med 148 5 2008 Mar 4 337 347 PubMed PMID: 18316752. Pubmed Central PMCID: Source: NLM. NIHMS100891. Source: NLM. PMC2674327. English